Antivirals and Therapeutics for Flu disease

Antiviral drugs are prescription medicines that fight agaist the flu in your body. The two classes of antiviral drugs used against influenza are neuraminidase inhibitors (oseltamivir and zanamivir) and M2 protein inhibitors (adamantane derivatives). Food and Drug Administration (FDA) and European Agency for the Evaluation of Medicinal Products(EMEA), now a days force developers as well as manufacturers to improve their production and purification processes for viral vectors and vaccines.

Influenza is a highly infectious viral disease which can occur as a pandemic, epidemic, outbreak and in form of sporadic cases. influenza A viruses that infect humans, three major subtypes of hemagglutinins (H1, H2, and H3) and two subtypes of neuraminidases (N1 and N2). Type A has been associated with widespread epidemics and pandemics, while type B has been infrequently implicated in regional epidemics. Influenza type C infections cause only a mild respiratory illness. Humans are the primary reservoir. Animal reservoirs are suspected as sources of new human subtypes and may occur particularly when people and livestock (for example pigs and poultry) live closely together. Surveillance data is used to identify and monitor the arrival of influenza, its geographic spread, intensity of activity, characteristics of those infected, as well as severity and changing trends in order to guide prevention and control recommendations.

  • Antiviral drugs for influenza
  • Antiviral drug development and treatment strategies, including vaccination
  • Advances in viral detection and identification technologies
  • Antibiotic and antimicrobial resistance during flu infection
  • National and international surveillance and contingency strategies
  • Antibiotic and antimicrobial resistance during flu infection

Related Conference of Antivirals and Therapeutics for Flu disease

May 30-31, 2018

Global experts meet on STD-AIDS and Infectious Diseases

Auckland, New Zealand
June 11-12, 2018

4th World Congress on Rare Diseases and Orphan Drugs

Dublin, Ireland
July 26-27, 2018

11th Global Infections Conference

Melbourne, Australia
August 20-21, 2018

Annual Meeting on Infectious Diseases

Prague, Czech Republic
August 20-21, 2018

Global HIV/AIDS Congress

Prague, Czech Republic
August 27-28, 2018

9th International Conference on Emerging Infectious Diseases

Zurich, Switzerland
August 27-29, 2018

Gulf Congress on Rare Diseases

Dubai, UAE
August 29-30, 2018

5th International Conference on Neglected Tropical & Infectious Diseases

| Boston, Massachusetts, USA
August 29-30, 2018

5th Annual Congress on Rare Diseases and Orphan Drugs

Boston, Massachusetts, USA
August 29-30, 2018

4th Annual Congress on Infectious Diseases

Boston, Massachusetts, USA
September 03-04,2018

Global Experts Meeting on Infectious Diseases

September 17-19, 2018

8th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa
September 27-29, 2018

10thEuro-Global Conference on Infectious Diseases

Rome, Italy
October 11-12, 2018

14th World Congress on Infection Prevention and Control

Moscow, Russia
October 18-20, 2018

World Polycystic Ovarian Syndrome Congress

Abu Dhabi, UAE
Dec 05-06, 2018

6th International Conference On Infectious Diseases

Lisbon, Portugal
Feb 25-26, 2019

6th International Congress on Infectious Diseases

London, United Kingdom

Antivirals and Therapeutics for Flu disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in